A Multimodal AI Agent for Ophthalmic Clinical Decision Support

Starting soon · Not applicable

Conditions studied: Ophthalmology, Large Language Models, AI Agent, Eye Disease, Retinal Disease

In brief

This study is a multicenter randomized controlled trial evaluating the effectiveness and safety of EyeAgent, a multimodal artificial intelligence (AI) agent designed to assist ophthalmologists in clinical decision-making. Participants will be recruited from ophthalmology clinics and hospitals in Hong Kong and mainland China. The AI agent acts as a digital co-pilot, analyzing patient images and clinical history to provide diagnostic and management recommendations. The trial aims to determine whether the use of the AI agent improves diagnostic accuracy, treatment decision-making performance, report generation, workflow efficiency, and user satisfaction compared to standard clinical practice.

Key facts

Study ID
NCT07401459
Run by
The Hong Kong Polytechnic University
People needed
300
Starts
2026-03-01
Expected to finish
2026-12-31
Last updated by the study team
2026-02-23

Who can join

Age: 6 and older, up to 75. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.